As of 2024-12-15, the EV/EBITDA ratio of MEI Pharma Inc (MEIP) is -0.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MEIP's latest enterprise value is 11.03 mil USD. MEIP's TTM EBITDA according to its financial statements is -37.58 mil USD. Dividing these 2 quantities gives us the above MEIP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 15.1x | 13.8x |
| Forward P/E multiples | 13.4x - 15.3x | 15.0x |
| Fair Price | (63.28) - 36.86 | (20.34) |
| Upside | -2443.9% - 1265.0% | -853.2% |
| Date | EV/EBITDA |
| 2024-12-13 | -0.29 |
| 2024-12-12 | -0.29 |
| 2024-12-11 | -0.29 |
| 2024-12-10 | -0.31 |
| 2024-12-09 | -0.31 |
| 2024-12-06 | -0.29 |
| 2024-12-05 | -0.29 |
| 2024-12-04 | -0.30 |
| 2024-12-03 | -0.31 |
| 2024-12-02 | -0.30 |
| 2024-11-29 | -0.31 |
| 2024-11-27 | -0.31 |
| 2024-11-26 | -0.32 |
| 2024-11-25 | -0.30 |
| 2024-11-22 | -0.31 |
| 2024-11-21 | -0.31 |
| 2024-11-20 | -0.31 |
| 2024-11-19 | -0.32 |
| 2024-11-18 | -0.32 |
| 2024-11-15 | -0.33 |
| 2024-11-14 | -0.35 |
| 2024-11-13 | -0.35 |
| 2024-11-12 | -0.37 |
| 2024-11-11 | -0.37 |
| 2024-11-08 | -0.35 |
| 2024-11-07 | -0.35 |
| 2024-11-06 | -0.35 |
| 2024-11-05 | -0.35 |
| 2024-11-04 | -0.36 |
| 2024-11-01 | -0.36 |
| 2024-10-31 | -0.36 |
| 2024-10-30 | -0.37 |
| 2024-10-29 | -0.38 |
| 2024-10-28 | -0.36 |
| 2024-10-25 | -0.30 |
| 2024-10-24 | -0.30 |
| 2024-10-23 | -0.30 |
| 2024-10-22 | -0.30 |
| 2024-10-21 | -0.30 |
| 2024-10-18 | -0.31 |
| 2024-10-17 | -0.30 |
| 2024-10-16 | -0.31 |
| 2024-10-15 | -0.30 |
| 2024-10-14 | -0.29 |
| 2024-10-11 | -0.29 |
| 2024-10-10 | -0.29 |
| 2024-10-09 | -0.29 |
| 2024-10-08 | -0.30 |
| 2024-10-07 | -0.31 |
| 2024-10-04 | -0.31 |